Ns Pharma: Preliminary Safety Results Indicated That All Adverse Events That Occurred Under Viltolarsen Treatment Were Mild or Moderate
Ns Pharma:初步安全結果表明,在Viltolarsen治療下發生的所有不良事件均爲輕度或中度
Ns Pharma: Preliminary Safety Results Indicated That All Adverse Events That Occurred Under Viltolarsen Treatment Were Mild or Moderate
Ns Pharma:初步安全結果表明,在Viltolarsen治療下發生的所有不良事件均爲輕度或中度
譯文內容由第三人軟體翻譯。